Apolipoprotein E and Alzheimer disease - Test2 - elhamkhani - TriplyDB

Apolipoprotein E and Alzheimer disease

Apolipoprotein E and Alzheimer disease

http://www.wikidata.org/entity/Q24563061

about

Neuropathology of non-Alzheimer degenerative disorders Tau-associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E A novel functional role for apolipoprotein B in male infertility in heterozygous apolipoprotein B knockout mice The low density lipoprotein receptor gene family. Differential expression of two alpha2-macroglobulin receptors in the brain Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells Cognitive impairment among World Trade Center responders: long-term implications of re-experiencing the 9/11 terrorist attacks Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.Safety and efficacy assessment of standardized herbal formula PM012.Accessing genomic data through XML-based remote procedure calls.Analysis of genetic linkage data for Mendelian traits.Straightforward detection of SNPs in double-stranded DNA by using exonuclease III/nuclease S1/PNA system.Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years.The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease Increased Amyloid Precursor Protein and Tau Expression Manifests as Key Secondary Cell Death in Chronic Traumatic Brain Injury.Type 2 diabetes as a risk factor for cognitive impairment: current insights.Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia.ACAT inhibition and amyloid beta reduction.Seizures and epilepsy in Alzheimer's disease Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium.Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.Possible Alzheimer's disease in an apolipoprotein E2 homozygote.Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy Probable early-onset Alzheimer's disease in an apolipoprotein E2 homozygote Secretases as targets for drug design in Alzheimer's disease.Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution Pharmacogenomics for the treatment of dementia.Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity.Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk.Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex

P2860

Q24657571-2F184B62-86DD-4A1A-AAEF-BF99D37D6B3C Q28211236-E58A15EC-6AE4-4555-99AE-5B08189C76F8 Q28298111-1A70D603-4C9D-42B6-B1D8-25BA1C6C1B9C Q28345684-CDF31DA8-8D9B-448D-AA10-232740DC741E Q28508278-3345B12A-9A9B-447F-8438-197BCCDA7954 Q28508453-10F7E2E8-C355-4177-A5CA-EFEC73EB3B66 Q28575743-EC718AF8-26F7-4475-8975-257DCF18390A Q28771380-04D4DFFD-2963-4F30-BC75-B635AFC87D43 Q28950649-A5B7B920-3008-4689-BE58-C1D487248EF1 Q30054419-2ECD56B8-F49B-4971-9A66-19474B39B431 Q30435790-F23148CD-86C1-42BD-B9B3-C4DF3B5610F5 Q30513935-8EDAC7E6-E3B7-4B7B-827E-E57D5F176C62 Q30751688-2A5CCD73-EC8B-4D4A-8824-05E53A53C606 Q30856799-394EBB27-996A-4BA4-AD4E-FE6F4EEA395F Q33198616-05EAF433-801F-4593-B3FE-99526CE8995D Q33657778-4B2E5039-ADCD-4683-9C34-D1A436EC12AB Q33678113-2CB3BF6B-9D3F-4780-B119-88298903F89C Q33681727-84BF74B8-BB7C-428E-BD37-86242396EA26 Q33834046-994568C8-C05C-4FD3-BA12-04455C1C992A Q33857774-800CEAC6-496E-48FF-AA1C-E9EE53ED89C5 Q33936708-36BB9A5E-08FF-46AF-8522-5E5D387BCC3F Q33940352-4D27CABE-DA38-4BD5-9224-F0269EAB0F69 Q34052308-BB3564C1-6D40-4833-9F08-84D5DD9B8F3D Q34070798-9020DAFB-CE30-4084-88D0-615369688AB2 Q34144298-1F2126B3-AA2E-4CE7-93EB-E931E26D6363 Q34160589-E2EC8AC9-07E1-4EB8-BDBA-A22065B3E340 Q34179881-8BF97618-309C-4B25-8328-6BF263BFBDE6 Q34188538-5D0FDC68-2EB4-4E0B-AF2D-96982AAA1FF4 Q34198068-AB56C56D-414E-4A59-8DAD-2AE9E4150ADC Q34219814-F17AC648-EA6F-4CBA-A8C1-E73C2FC94F25 Q34354478-2DCB9EE2-2305-4F36-B8BD-F4A1AC83E191 Q34536036-A4EB5162-6328-435B-BCFD-E3BF33122401 Q34648195-7034AFB1-9032-4F34-8631-FDF889A8932B Q34784469-EBFBCAF6-B36D-426C-89C4-E7F91B9E5624 Q35001010-BFB9A244-70EC-424F-B9E2-48EE6805CE6B Q35009345-7C2DC508-7E11-4D95-91C7-CABD90C64ADD Q35060115-FDE2D273-B935-4831-9A50-8E956B601A97 Q35167339-C557D361-BB85-44D8-AFC4-3C402A3DBD3B Q35232774-6AC83A69-CF62-404F-AD8E-530879A1F7F3 Q35238425-ABBD93EC-82D7-400A-A068-AD15937C2257

P2860

Apolipoprotein E and Alzheimer disease

http://www.wikidata.org/entity/Q24563061

description

1995 nî lūn-bûn

@nan

1995 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

name

Apolipoprotein E and Alzheimer disease

@ast

Apolipoprotein E and Alzheimer disease

@en

Apolipoprotein E and Alzheimer disease

@nl

type

label

Apolipoprotein E and Alzheimer disease

@ast

Apolipoprotein E and Alzheimer disease

@en

Apolipoprotein E and Alzheimer disease

@nl

prefLabel

Apolipoprotein E and Alzheimer disease

@ast

Apolipoprotein E and Alzheimer disease

@en

Apolipoprotein E and Alzheimer disease

@nl

P1433

Q24563061-740C079C-59F6-42F2-91B6-BA04D20FB186

P1476

Q24563061-402E11C7-0A45-46F0-B06F-AF55AB505609

P2093

Q24563061-21BC0BF1-0995-4A63-92C9-24C5DD96D47F

Q24563061-794B6E4A-52BF-493E-9F77-4E3B5B88BAD1

P2860

Q24563061-0DA88461-3434-4D4B-AE0C-D330CDA876BB

Q24563061-0F73C520-30CB-4A9A-B774-327530E83AC2

Q24563061-1D5946F1-279F-411C-9E70-960A1572A869

Q24563061-2B3709F6-48DB-4BB4-BECE-770968010E44

Q24563061-3B822356-585D-46CE-916E-ED96B4E9FEC3

Q24563061-43E70C4C-5E28-4702-9E52-126F1C36FA7B

Q24563061-47CAA562-20FF-4DE8-8AD3-02A23F1DF90C

Q24563061-4E73E4A2-CF13-46F6-9C88-541085A09095

Q24563061-6DB919F5-EC9D-40EE-865E-E5013A080A43

Q24563061-782753D6-5C2F-4F34-A2A1-A84663F332AD

P304

Q24563061-96737A90-0964-4D69-A776-1B5D771A3764

P31

Q24563061-49e74f1a-4ba1-4d23-8d9a-111c5656ddec

Q24563061-7C506DE7-EE9C-4C6D-857D-F29331C12BF1

P3181

Q24563061-AA542051-1A74-400B-8FCA-0C7A4B943E38

P356

Q24563061-32763F70-2D7A-4C81-A621-AA3A86952BB6

P407

Q24563061-6108D5A8-062E-46F5-B707-92F3A36EE812

P433

Q24563061-27D7D300-3151-458C-803E-E381A79C634A

P478

Q24563061-80015125-A73C-48E5-9A3B-47A942610ECE

P577

Q24563061-F98C64AC-C930-4968-A049-C35FA3C1C220

P5875

Q24563061-07A7E610-77E5-4ACA-8FED-FA38416729F1

P698

Q24563061-5C0AD9D5-7112-48DB-B19F-D257B1363A35

P921

Q24563061-64122675-ACA1-492A-AF20-1547F0F43701

P932

Q24563061-44073001-3B46-4485-848A-3EA7D7B078D7

P3181

P356

PNAS.92.11.4725

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Apolipoprotein E and Alzheimer disease

@en

P2093

A D Roses

http://www.w3.org/2001/XMLSchema#string

W J Strittmatter

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study

Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

P304

4725-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3975368

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.92.11.4725

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235615705

http://www.w3.org/2001/XMLSchema#string

P698

7761390

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

41779

http://www.w3.org/2001/XMLSchema#string